arrow_back Civic Audit
Share share

Improved Drug Access: Public Input on Medication Strategy Changes.

This bill aims to increase public involvement in decisions about drug accessibility. The Secretary of Health and Human Services must open a public forum for comments on proposed changes to drug risk evaluation and mitigation strategies, including those affecting patient access to medication. This means your experiences and opinions can help shape drug policy.
Key points
Establishment of a public forum for comments on changes to drug safety strategies.
Opportunity for citizens to influence drug accessibility and administration.
Government report assessing the impact of changes on patient access to drugs.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_7649
Sponsor: Rep. Joyce, John [R-PA-13]
Process start date: 2022-05-03
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_7649.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-05-03.

What are the main provisions?

Key points include:

  • Establishment of a public forum for comments on changes to drug safety strategies.
  • Opportunity for citizens to influence drug accessibility and administration.
  • Government report assessing the impact of changes on patient access to drugs.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Joyce, John [R-PA-13].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health